Anthrax as a Biological Weapon, 2002
JAMA·
- DOI
- 10.1001/jama.287.17.2236
- PMID
- 11980524
- PMCID
- —
- OpenAlex
- W2150832852
- Study type
- Guideline
- Publisher
- American Medical Association (AMA)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
By consolidating diagnostic, therapeutic, prophylactic, vaccination, surveillance, and decontamination guidance into a single consensus document informed by the 2001 attacks, the paper is positioned as a reference for preparedness and response to bioterrorism involving anthrax.
Structured evidence summary
Research question
The paper revisits and updates consensus-based recommendations for medical and public health professionals responding to a deliberate Bacillus anthracis release against civilians.
Study design
It is a consensus-based guideline developed by a 23-member multi-institutional working group, supported by a structured MEDLINE search (1966 to January 2002) and supplementary reference and unpublished source review, with iterative drafting and written comment incorporation.
Population and setting
The intended audience is medical and public health professionals managing a civilian population after an intentional B. anthracis release, drawing on expertise from academic, research, governmental, military, public health, and emergency management institutions, largely U.S.-based.
Main findings
The updated consensus statement provides recommendations on anthrax diagnosis, indications for vaccination, therapy, postexposure prophylaxis, environmental decontamination, and suggested research. It incorporates lessons from the 2001 U.S. anthrax attacks, including revised clinical and laboratory clues, vaccine information, updated antibiotic considerations, and judgments about environmental surveillance and decontamination.
Public-health relevance
By consolidating diagnostic, therapeutic, prophylactic, vaccination, surveillance, and decontamination guidance into a single consensus document informed by the 2001 attacks, the paper is positioned as a reference for preparedness and response to bioterrorism involving anthrax.
Important limitations
The abstract does not list explicit study limitations. The summary is therefore limited to the supplied single-article abstract and metadata and requires the original paper, including its detailed recommendation grading and any caveats, for decision-grade interpretation.
GIDS interpretation
From a discoverability standpoint, the paper is a widely cited, peer-reviewed JAMA consensus guideline indexed under anthrax and bioterrorism-related topics, useful as contextual background literature. This editorial summary does not link the paper to any live surveillance signal or current outbreak intelligence.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 20 auditable classifier relationships to diseases, places, topics, and study design.